We are live on ! Find out more
VRCA icon

Verrica Pharmaceuticals
VRCA

44 hedge funds and large institutions have $103M invested in Verrica Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

49% more capital invested

Capital invested by funds: $69.1M → $103M (+$34M)

33% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 12

0% more ownership

Funds ownership: 3.46% → 3.46% (+0%)

6% less funds holding

Funds holding: 47 → 44 (-3)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

Holders
44
Holders Change
-3
Holders Change %
-6.38%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
16
Reduced
12
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$313K
2
DMK
David M. Knott
+$280K
3
Bank of New York Mellon
Bank of New York Mellon
New York
+$173K
4
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
+$159K
5
CIAS
Capital Investment Advisory Services
North Carolina
+$139K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$989K
2
ZIM
Zacks Investment Management
Illinois
-$279K
3
Millennium Management
Millennium Management
New York
-$254K
4
SRAM
Spouting Rock Asset Management
Pennsylvania
-$117K
5
TRCT
Tower Research Capital (TRC)
New York
-$104K

VRCA Hedge Fund Activity: Q4 2020 in Review

44 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Verrica Pharmaceuticals (VRCA) for Q4 2020, worth a combined $103M — up 49% from $69.1M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of VRCA and 3 opened new positions — a net loss of 3 holders — while 12 trimmed existing stakes and 16 added.

The largest buyer was BlackRock, adding an estimated $313K. The largest seller was Fidelity Investments, cutting an estimated $989K.

  • 44 institutional investors held Verrica Pharmaceuticals (VRCA) as of Q4 2020, down from 47 in Q3 2020.
  • Funds reported $103M of Verrica Pharmaceuticals stock for Q4 2020, up 49% quarter-over-quarter.
  • 3 funds opened new Verrica Pharmaceuticals positions in Q4 2020 and 6 closed out, a net change of -3 holders.
  • The largest Verrica Pharmaceuticals buyer in Q4 2020 was BlackRock, an estimated $313K added.
  • The largest Verrica Pharmaceuticals seller in Q4 2020 was Fidelity Investments, an estimated $989K sold.

Based on aggregated 13F filings for Q4 2020.